Tech Company Financing Transactions
Crown Bioscience Funding Round
Crown Bioscience closed a $26.6 million Series D funding round on 5/26/2014. Backers included Lilly Asia Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/26/2014
Transaction Type
Venture Equity
Amount
$26,600,000
Round
Series D
Investors
Lilly Asia Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16550 West Bernardo Dr. Building 5 525
San Diego, CA 92127
USA
San Diego, CA 92127
USA
Phone
Website
Email Address
Not Recorded
Overview
CrownBio is at the forefront of oncology research and cancer immunotherapy providing the largest commercial collection of well-characterised patient derived xenograft models.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jean-Pierre Wery
Chief Financial Officer
Eva Ho
Vice President
Leon Hall
Vice President
Henry Li
VP - Operations
Yangzhou Wang
VP - R & D
Yixin Wang
Browse more venture capital transactions:
Prev: 5/26/2014: Bellabeat venture capital transaction
Next: 5/26/2014: Priori Data venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs